{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:48:22Z","timestamp":1784342902525,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.earlhumdev.2012.09.019","type":"journal-article","created":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T17:01:18Z","timestamp":1350320478000},"page":"937-941","source":"Crossref","is-referenced-by-count":42,"title":["Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors"],"prefix":"10.1016","volume":"88","author":[{"given":"Helen A.","family":"Mintz-Hittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2012.09.019_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"issue":"11","key":"10.1016\/j.earlhumdev.2012.09.019_bb0010","first-page":"991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"The Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.earlhumdev.2012.09.019_bb0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archopht.124.11.1669-c","article-title":"Standard image of plus disease in retinopathy of prematurity","volume":"124","author":"Capone","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.earlhumdev.2012.09.019_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1542\/peds.2005-2749","article-title":"Screening examination of premature infants for retinopathy of prematurity (policy statement)","volume":"117","author":"Section of Ophthalmology AAoP","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.earlhumdev.2012.09.019_bb0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1542\/peds.2006-2162","article-title":"Errata: screening examination of premature infants for retinopathy of prematurity (policy statement)","volume":"118","author":"Section of Ophthalmology AAoP","year":"2006","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.earlhumdev.2012.09.019_bb0030","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.earlhumdev.2012.09.019_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results","volume":"106","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.earlhumdev.2012.09.019_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.earlhumdev.2012.09.019_bb0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0161-6420(94)31301-7","article-title":"Postnatal retinal vascularization in former preterm infants with retinopathy of prematurity","volume":"101","author":"Mintz-Hittner","year":"1994","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.earlhumdev.2012.09.019_bb0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0161-6420(99)00732-0","article-title":"A small avascular zone may be an historic mark of prematurity","volume":"106","author":"Mintz-Hittner","year":"1999","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.earlhumdev.2012.09.019_bb0055","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreal bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.earlhumdev.2012.09.019_bb0060","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archophthalmol.2010.145","article-title":"Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment","volume":"128","author":"Hoang","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.earlhumdev.2012.09.019_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity: preliminary results of the BEAT-ROP clinical trial","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.earlhumdev.2012.09.019_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","article-title":"Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan","volume":"118","author":"Wu","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.earlhumdev.2012.09.019_bb0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5301\/ejo.5000166","article-title":"Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II","volume":"22","author":"Autrata","year":"2012","journal-title":"Eur J Ophthalmol"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378212002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378212002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:21:44Z","timestamp":1542673304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378212002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0378378212002411"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2012.09.019","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}